Drug Profile
HU 010
Alternative Names: HU010Latest Information Update: 19 Dec 2015
Price :
$50
*
At a glance
- Originator Huons
- Developer Chungnam National University; College of Medicine Korea University; Dongguk University; Huons
- Class
- Mechanism of Action Adenosine A3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 17 Dec 2015 No development reported - Phase-II for Stroke in South Korea (unspecified route)
- 31 Dec 2011 Phase-II clinical trials in Stroke in South Korea (unspecified route) (Huons pipeline, December 2015)
- 31 Dec 2008 Preclinical trials in Stroke in South Korea (unspecified route)